IDL Biotech second quarter report 2017 | IDL Biotech
IDL Biotech

CLOSE MENU

August 2017

IDL Biotech second quarter report 2017

Charlotte Berg leaves the position as CEO of IDL Biotech AB (publ)

IDL Biotech's CEO, Charlotte Berg, has informed the Board that, after more than ten years at the company, she wishes to resign as CEO to start another assignment in a non-competing company.

Information från årsstämman den 27 maj 2020

IDL Biotech AB (publ) avhöll årsstämma på onsdagen den 27 maj 2020.

IDL Biotech

Skip this intro